Feedback / Questions
aceclidine (LNZ100) - Alvogen
https://www.globenewswire.com/news-release/2025/05/09/3078287/0/en/LENZ-Therapeutics-and-Lotus-Pharmaceutical-Announce-Exclusive-License-and-Commercialization-Agreement-for-LNZ100-in-the-Republic-of-Korea-and-Southeast-Asia.html
May 9, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next